MARRONE BIO INNOVATIONS INC's ticker is MBII and the CUSIP is 57165B106. A total of 32 filers reported holding MARRONE BIO INNOVATIONS INC in Q3 2015. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $12,000 | +50.0% | 5,563 | +24.1% | 0.00% | – |
| Q3 2016 | $8,000 | +166.7% | 4,483 | +11.4% | 0.00% | – |
| Q2 2016 | $3,000 | -92.9% | 4,024 | -91.5% | 0.00% | – |
| Q1 2016 | $42,000 | -25.0% | 47,118 | -6.9% | 0.00% | – |
| Q4 2015 | $56,000 | -45.1% | 50,608 | +4.8% | 0.00% | – |
| Q3 2015 | $102,000 | +29.1% | 48,313 | +21.4% | 0.00% | – |
| Q2 2015 | $79,000 | -94.6% | 39,784 | -89.5% | 0.00% | – |
| Q1 2015 | $1,471,000 | +6.4% | 380,180 | -0.7% | 0.00% | – |
| Q4 2014 | $1,382,000 | +63.4% | 382,938 | +20.5% | 0.00% | – |
| Q3 2014 | $846,000 | -73.1% | 317,917 | +17.6% | 0.00% | -100.0% |
| Q2 2014 | $3,140,000 | +45.2% | 270,242 | +74.5% | 0.00% | 0.0% |
| Q1 2014 | $2,163,000 | -17.0% | 154,829 | +5.6% | 0.00% | 0.0% |
| Q4 2013 | $2,607,000 | +1.3% | 146,643 | -4.0% | 0.00% | 0.0% |
| Q3 2013 | $2,574,000 | – | 152,760 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARDSLEY ADVISORY PARTNERS LP | 14,303,099 | $15,635,000 | 3.02% |
| ICM ASSET MANAGEMENT INC/WA | 21,500 | $26,000 | 0.14% |
| Fairpointe Capital LLC | 613,900 | $749,000 | 0.12% |
| WADDELL & REED FINANCIAL INC | 25,095,634 | $30,617,000 | 0.07% |
| WEDBUSH SECURITIES INC | 37,129 | $45,000 | 0.00% |
| Financial Advocates Investment Management | 30,925 | $38,000 | 0.00% |
| PRIMECAP MANAGEMENT CO/CA/ | 2,035,300 | $2,483,000 | 0.00% |
| Avior Wealth Management, LLC | 10,000 | $12,000 | 0.00% |
| AMALGAMATED BANK | 10,217 | $12,000 | 0.00% |
| Tower Research Capital LLC (TRC) | 73,897 | $90,000 | 0.00% |